Beijing Biostar Pharmaceuticals Co., Ltd. — Proxy Solicitation & Information Statement 2026

May 28, 2026

华昊中天

Biostar

Beijing Biostar Pharmaceuticals Co., Ltd.

北京華昊中天生物醫藥股份有限公司

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock code: 2563)

FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING

TO BE HELD ON FRIDAY, 26 JUNE 2026 (Note 1)

I/We (Name) (Note 2)

of (Address)

being the registered holder(s) of (Note 3) __ unlisted shares/

H shares (Note 4) of RMB1.00 each in the share capital of Beijing Biostar Pharmaceuticals Co., Ltd. (the "Company") hereby

appoint (Name)

of (Address)

or failing him/her, (Name)

of (Address)

or failing him/her, THE CHAIRMAN OF THE MEETING (Note 5) as my/our proxy to attend and vote for me/us and on my/our behalf at the annual general meeting (the "AGM") of the Company to be held at 1202B, 12/F, Building 3, No. 22 Ronghua Middle Road, Beijing Economic-Technological Development Area, Beijing, PRC on Friday, 26 June 2026 at 3:00 p.m. and at any adjournment thereof or on any resolution or motion which is proposed thereat. My/Our proxy is authorised and instructed to vote as indicated (Note 6) in respect of the undermentioned resolutions:

Ordinary Resolutions		For	Against
1.	To consider and approve the audited consolidated financial statements for the year ended 31 December 2025.
2.	To consider and approve the annual report of the Company for the year ended 31 December 2025.
3.	To consider and approve the profit distribution proposal of the Company for the year ended 31 December 2025.
4.	To consider and approve the report of the board of directors (the “Board”) of the Company for the year ended 31 December 2025.
5.	To consider and approve the duty report of independent non-executive Director for the year ending 31 December 2025.
6.	To consider and approve the report of the supervisors committee of the Company for the year ended 31 December 2025.
7.	To consider and ratify the connected transaction for the year ended 31 December 2025.
8.	To consider and approve the Company's directors' remuneration package for the year ending 31 December 2026.
9.	To consider and appoint Dr. Zhu Xiaodong as the independent non-executive Director.
10.	To consider and approve the re-appointment of WUYIGE Certified Public Accountants LLP as the auditor of the Company for the year ending 31 December 2026, and to authorize the Board to determine their remuneration.
Special Resolutions (Note 6)		For	Against
11.	To consider and approve the proposed granting of the general mandate to the Board to issue new Shares.
12.	To consider and approve the proposed granting of the general mandate to the Board to repurchase H Shares.
13.	To consider and approve the proposed cancellation of the supervisory committee and amendment the Articles of Association.

---

Special Resolutions^{(Note 6)}		For	Against
14.	To consider and adopt the Share Option Scheme.
15.	To consider and authorised the Board and/or Authorisation Person to handle matters pertaining to the Share Option Scheme.

Dated this __ day of, __ 2026

Signature(s) ^{(Note 6)} ____

Notes:

1. IMPORTANT: You should first review the annual report of the Company for the year 2025 and the notice of the AGM dated 28 May 2026. The annual report for the year 2025 includes the directors’ report for the year 2025 and the audited consolidated financial report of the Company for the year 2025 for review by shareholders.

2. Please insert the full name(s) (in Chinese or English) and address(es) (as shown in the register of members) in BLOCK CAPITALS.

3. Please insert the number of shares registered in your name(s); if no number is inserted, this form of proxy will be deemed to relate to all the shares in the capital of the Company registered in your name(s).

4. Please strike out the type of shares (unlisted shares or H shares) to which this form of proxy does not relate.

5. If any proxy other than the Chairman of the Meeting is preferred, please strike out the words “THE CHAIRMAN OF THE MEETING” and insert the name and address of the proxy desired in the space provided. A shareholder entitled to attend and vote at the AGM may appoint one or more proxies to attend and vote on his behalf. A proxy need not be a shareholder of the Company but must attend the AGM in person to represent you. As regards any shareholder which is a corporation, its legal representative or any person duly authorised pursuant to a resolution of its board of directors or any other decision-making body shall attend the AGM as its representative. ANY ALTERATION MADE TO THIS FORM OF PROXY MUST BE INITIALLED BY THE PERSON WHO SIGNS IT.

6. IMPORTANT: IF YOU WISH TO VOTE FOR ANY RESOLUTION, PLEASE TICK THE BOX MARKED “For”. IF YOU WISH TO VOTE AGAINST ANY RESOLUTION, PLEASE TICK THE BOX MARKED “Against”. Failure to tick a box will entitle your proxy to cast your vote at his/her discretion. Your proxy will also be entitled to vote at his/her discretion on any resolution properly put to the meeting other than those referred to in the notice convening the meeting.

7. If the appointor is a corporation, this form must be under common seal or under the hand of an officer or attorney duly authorised on that behalf.

8. In the case of joint holders, both holders should sign on the proxy form and the names of all the joint holders should be stated.

Where there are joint holders of any share of the Company, any one of such joint holders may vote at the meeting, either in person or by proxy, in respect of such share as if he/she were solely entitled thereto, but if more than one of such joint holders be present at the meeting, the vote of the senior who tenders a vote, whether in person or by proxy, will be accepted to the exclusion of the votes of the other joint holders, and for this purpose seniority shall be determined as that one of the said persons so present whose name stands first on the register of members in respect of such share shall alone be entitled to vote in respect thereof.

1. In order to be valid, a proxy form and the power of attorney or other authority (if any) under which it is signed, or a notarially certified copy of such power of attorney, must be deposited at the Company’s H share registrar of the Company in Hong Kong, Computershare Hong Kong Investor Services Limited, at 1712–1716, 17th Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong, not less than 24 hours before the time fixed for holding the meeting or any adjournment thereof. Completion and delivery of this proxy form will not preclude you from attending and voting at the meeting if you so wish.

2. A proxy need not be a member of the Company.